Journal article
Decentralized, community-based hepatitis C point-of-care testing and direct-acting antiviral treatment for people who inject drugs and the general population in myanmar: Protocol for a feasibility study
BL Draper, A Pedrana, J Howell, WL Yee, H Htay, KS Aung, S Shilton, KP Kyi, W Naing, M Hellard
Jmir Research Protocols | JMIR PUBLICATIONS, INC | Published : 2020
DOI: 10.2196/16863
Open access
Abstract
Background: The advent of direct-acting antivirals (DAAs) and point-of-care (POC) testing platforms for hepatitis C allow for the decentralization of care to primary care settings. In many countries, access to DAAs is generally limited to tertiary hospitals, with limited published research documenting decentralized models of care in low-and middle-income settings. Objective: This study aims to assess the feasibility, acceptability, effectiveness, and cost-effectiveness of decentralized community-based POC testing and DAA therapy for hepatitis C among people who inject drugs and the general population in Yangon, Myanmar. Methods: Rapid diagnostic tests for anti-hepatitis C antibodies were car..
View full abstractGrants
Funding Acknowledgements
This study was funded as part of the Unitaid HEAD-Start Project through FIND. The investigators are responsible for the study design, data collection and analysis, interpretation of data, and preparation of manuscripts. The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute.